Form 8-K - Current report:
SEC Accession No. 0001645113-24-000034
Filing Date
2024-12-02
Accepted
2024-12-02 07:00:16
Documents
14
Period of Report
2024-12-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvcr-20241202.htm   iXBRL 8-K 26531
2 EX-99.1 specialreportdec2024pr.htm EX-99.1 18172
  Complete submission text file 0001645113-24-000034.txt   175235

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvcr-20241202.xsd EX-101.SCH 1882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvcr-20241202_lab.xml EX-101.LAB 21801
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvcr-20241202_pre.xml EX-101.PRE 12579
16 EXTRACTED XBRL INSTANCE DOCUMENT nvcr-20241202_htm.xml XML 2707
Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Filer) CIK: 0001645113 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37565 | Film No.: 241517393
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)